Our influential research and analysis attracts the attention of leading publishers every day.

The expansion of the insured population, prompted by the introduction of Patient Protection and Affordable Care Act (PPACA), will play a key role in driving US pharmaceutical market revenue up by a third by the end of the decade.

High potential as a combination therapy and a better safety profile will see Arena’s new obesity drug Belviq surpass Vivus’ challenger Qsymia in the near-term battle to become the market’s dominant treatment, predicts an analyst with research and consulting firm GlobalData.

While the Australian LNG sector has massive financial potential, ballooning development costs, driven by the prodigious strength of the Australian dollar, are continuing to chip away at profit forecasts. But despite the emergence of such a challenging macroeconomic environment, the national governm

European Commission investigators raided the trading offices of three major oil companies and a price reporting agency this week amid complaints about price-fixing and collusion in the global crude oil, refined products and biofuels markets.

While the risks involved in HIV vaccine development have turned Big Pharma away from pursuing a preventative vaccine, government-funded organizations and smaller biotech firms may provide the answer, a GlobalData analyst has said in a research note as World AIDS Vaccine Day approaches.

The introduction of new hepatitis C (HCV) drugs in the second half of 2013 will result in a significant increase in annual treatment costs and can lead to insurers slashing the number of patients eligible for coverage.

Italian pharmaceutical market value will continue to fall in the foreseeable future, due to government support of generics and a stringent drug pricing policy.

Bucking a global trend of falling revenues, weak penetration of generic drugs and an increasing patient population will ensure steady growth of Japan’s Chronic Myeloid Leukemia (CML) market over the next decade.

With the Affordable Care Act (ACA) now covering a range of preventative services within the women’s health sector, major generics manufacturers are taking key steps to ensure they maximize profits in a newly promising market.

China sits firmly behind the wheel of worldwide gasoline demand, as developed nations continue to struggle financially, states GlobalData’s lead refined products analyst.